Trident Lifeline Limited IPO Detail
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.
Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan licence.
Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs).
Trident Lifeline core business categories:
1. Ethical marketing of pharmaceutical formulation & products in the International Market through a third-party distribution network and sales force under its brand.
2. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market.
The company operate in India as well as African, Latin American and East Indian Countries. The company have a presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venuzela.
Company Promoters
Mr. Hardik Jigishkumar Desai, Mr. Mayurkumar Mansukhbhai Gajera, Mrs. Rupaben C Jariwala, Mrs. Rinkal Mayurbhai Gajera, Mr. Tarang Nathabhai Gajera and Mr. Mohak Nathabhai GajeraIPO Details
| IPO Opening Date | Sep 26, 2022 |
| IPO Closing Date | Sep 29, 2022 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹101 per equity share |
| Market Lot | 1200 Shares |
| Min Order Quantity | 1200 Shares |
| Listing At | BSE SME |
| Issue Size | ₹35.34 Cr |
| Fresh Issue | ₹35.34 Cr |
| Offer for Sale | - |
| Retail Portion | 50% |
IPO Subscription (Bidding Detail)
| AS On | QIB | SHNI | BHNI | NII | RII | TOTAL |
|---|---|---|---|---|---|---|
| Day 1 | - | - | 0.43x | 0.33x | 0.38x | |
| Day 2 | - | - | 1.69x | 0.98x | 1.34x |
IPO Tentative Timetable
The Trident Lifeline Limited IPO open date is Sep 26, 2022, and the close date is Sep 29, 2022. The issue may list on Oct 10, 2022.
| IPO Open Date | Sep 26, 2022 |
| IPO Close Date | Sep 29, 2022 |
| Basis of Allotment Date | Oct 04, 2022 |
| Initiation of Refunds | Oct 06, 2022 |
| Credit of Shares to Demat Account | Oct 07, 2022 |
| IPO Listing Date | Oct 10, 2022 |
IPO Lot Size
The Trident Lifeline Limited IPO market lot size is 1200 shares. A retail-individual investor can apply for up to 1 lots (1200 shares or ₹121200).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 1200 | ₹121200 |
| Maximum | 1 | 1200 | ₹121200 |
IPO Promoter Holding
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 69.57% |
Company Financials:
For the year/period ended (₹ in Lakhs)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-20 | 638.92 | 500.71 | -79.63 |
| 31-Mar-21 | 1144.41 | 978.13 | 63.23 |
| 31-Mar-22 | 1385.98 | 2237.14 | 227.32 |
Objects of the Issue:
The Issue Proceeds from the Fresh Issue will be utilized for the following objects:
1. To Meet Working Capital Requirements
2. Product registration in the international markets
3. General Corporate Purpose
4. To meet Public Issue Expenses
Trident Lifeline Limited IPO Registrar:
Link Intime India Private Ltd
Trident Lifeline Limited IPO Lead Manager(s):
Beeline Capital Advisors Pvt Ltd
Company Contact Information:
Trident Lifeline Limited
2nd Floor, Shop-2004,
North Extension, Falsawadi Begumpura, Nodh-4/1650,
Sahara Darwaja, Surat – 395003
